Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass | Title |
---|---|
1/00 | Drugs for disorders of the alimentary tract or the digestive system |
1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
Patent # | Title | Filing Date | Issue Date | Patent Owner |
---|---|---|---|---|
9,119,850 | Compositions and methods for weight loss in at risk patient populations | Mar 02, 15 | Sep 01, 15 | OREXIGEN THERAPEUTICS, INC. |
9,119,861 | Piroxicam-containing transdermally absorbable preparation | Dec 14, 10 | Sep 01, 15 | TEIKOKU SEIYAKU CO., LTD. |
9,119,869 | Mucin derived polypeptides | Apr 29, 11 | Sep 01, 15 | |
9,119,884 | LLP2A-bisphosphonate conjugates for osteoporosis treatment | Jan 19, 12 | Sep 01, 15 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
9,119,885 | RGD-containing peptidomimetics and uses thereof | Feb 07, 14 | Sep 01, 15 | STEBA BIOTECH S.A. |
9,120,778 | Uracil derivatives as AXL and c-MET kinase inhibitors | Apr 08, 15 | Sep 01, 15 | IGNYTA, INC. |
9,120,785 | Pyridyl aminopyridines as Syk inhibitors | May 04, 12 | Sep 01, 15 | MERCK SHARP & DOHME CORP. |
9,120,855 | Biologic compounds directed against death receptor 5 | Feb 09, 11 | Sep 01, 15 | NOVARTIS AG, |
9,119,394 | Anti-microbial polymers and their compositions | May 05, 10 | Sep 01, 15 | RECCE PTY LTD. |
9,119,414 | for dust mite allergy | Dec 08, 08 | Sep 01, 15 | N.V. NUTRICIA |
9,119,819 | Oral liquid compositions of rhein or diacerein | Sep 23, 08 | Sep 01, 15 | WOCKHARDT LTD. |
9,119,833 | Administration of relaxin to treat nephrogenic diseases of water imbalance involving aquaporin-4 | Nov 08, 13 | Sep 01, 15 | THE UNIVERSITY OF MELBOURNE, |
9,119,837 | Use of sEH inhibitors as analgesics | Aug 18, 06 | Sep 01, 15 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
9,119,772 | Androgen composition for treating an opthalmic condition | Jan 25, 12 | Sep 01, 15 | ALLERGAN, INC. |
9,119,773 | Toroidal pharmaceutical formulations | Jun 27, 12 | Sep 01, 15 | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
9,119,778 | Dry powder formulations and methods for treating pulmonary diseases | Mar 25, 15 | Sep 01, 15 | PULMATRIX OPERATING COMPANY, INC. |
9,119,816 | Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide | Aug 06, 13 | Sep 01, 15 | KANGWON NATIONAL UNIVERSITY UNIVERSITY-INDUSTRY COOPERATION FOUNDATION, |
9,119,826 | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels | Aug 13, 12 | Sep 01, 15 | PIVOTAL THERAPEUTICS, INC. |
9,114,096 | Skin compositions and methods of use thereof | Mar 26, 12 | Aug 25, 15 | LIVING PROOF, INC. |
9,114,107 | Compositions for inhibiting virus entry and promoting virolysis, and methods thereof | Oct 05, 11 | Aug 25, 15 | DREXEL UNIVERSITY |